Therapeutic regimen of Crohn's disease: effect of Infliximab combined with mesalazine on intestinal flora and inflammatory indexes in patients.

ABSTRACT:

SUBMITTER: Xiang X 

PROVIDER: S-EPMC12482166 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature